DUBLIN, Ireland and PRAGUE, Czech Republic, June 15 /PRNewswire-FirstCall/ -- Alltracel Pharmaceuticals Plc., ("Alltracel", or "the Company"), (AIM:AP.L), the Medical Technology Company focused on the Woundcare, Oralcare and Cardiovascular Health markets is pleased to report on the successful completion of the sterol based products and Alltracel Bioactive combination pre-clinical studies. This trial carried out in partnership with a number of existing functional food companies was part of the current series of pre-clinical trials examining dosage, timing/phasing, and the combination effects with specific commercially available sterol based products and omega-3 fatty acids.
